Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA502731
Max Phase: Preclinical
Molecular Formula: C14H11ClO2
Molecular Weight: 246.69
Molecule Type: Small molecule
Associated Items:
ID: ALA502731
Max Phase: Preclinical
Molecular Formula: C14H11ClO2
Molecular Weight: 246.69
Molecule Type: Small molecule
Associated Items:
Synonyms (1): 2-Chlorobenzyl Benzoate
Synonyms from Alternative Forms(1):
Canonical SMILES: O=C(OCc1ccccc1Cl)c1ccccc1
Standard InChI: InChI=1S/C14H11ClO2/c15-13-9-5-4-8-12(13)10-17-14(16)11-6-2-1-3-7-11/h1-9H,10H2
Standard InChI Key: GTNDJMMELYTFKN-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 246.69 | Molecular Weight (Monoisotopic): 246.0448 | AlogP: 3.70 | #Rotatable Bonds: 3 |
Polar Surface Area: 26.30 | Molecular Species: | HBA: 2 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 4.31 | CX LogD: 4.31 |
Aromatic Rings: 2 | Heavy Atoms: 17 | QED Weighted: 0.77 | Np Likeness Score: -0.93 |
1. Ohno O, Ye M, Koyama T, Yazawa K, Mura E, Matsumoto H, Ichino T, Yamada K, Nakamura K, Ohno T, Yamaguchi K, Ishida J, Fukamizu A, Uemura D.. (2008) Inhibitory effects of benzyl benzoate and its derivatives on angiotensin II-induced hypertension., 16 (16): [PMID:18672373] [10.1016/j.bmc.2008.03.056] |
Source(1):